Article Listing - Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High

CHILE'S PROFARMA SEEKING DEALS

23 March 1992

Laboratorios Profarma is one of Chile's smaller national pharmaceutical companies, but its size is not indicative of its importance in...

COMPARATIVE STUDY CALL WITH ZOFRAN

23 March 1992

Glaxo's 5-HT3 receptor antagonist anti-emetic Zofran (ondansetron) represents a great improvement on earlier anti-emetics for chemotherapy regimens that include cisplatin,...

MEDEVA ACQUIRES HEP-B PRODUCTS

23 March 1992

UK pharmaceuticals group Medeva is continuing its program of buying and developing pharmaceutical products with short development times with the...

GENENTECH'S DNase IN CYSTIC FIBROSIS

23 March 1992

Genentech's recombinant human deoxyribonuclease I (DNase) has been found to be safe in the treatment of cystic fibrosis patients. And...

SCHERER/FABRE DRUG DELIVERY ACCORD

23 March 1992

Pierre Fabre of France and US-based R P Scherer have entered into a collaborative agreement targeted at the development and...

GAMBRO PRETAX EARNINGS JUMP 46%

16 March 1992

Swedish company Gambro reported sales up 12.9% to 5.62 billion Swe-dish kroner ($943.8 million) for 1991, and pretax earnings of...

MEVACOR WORKS IN FDB, SAYS STUDY

16 March 1992

Familial defective apolipoprotein B-100 (FDB), an autosomal dominant disorder characterized by hyper-cholesterolemia, has been shown to be responsive to treatment...